Labcorp Expands Oncology Portfolio
Labcorp has expanded its precision oncology portfolio with new tests for solid tumors and blood cancers to support diagnostic development.
Read MorePosted by Chris Wolski | May 30, 2025 | Cancer |
Labcorp has expanded its precision oncology portfolio with new tests for solid tumors and blood cancers to support diagnostic development.
Read MorePosted by Andy Lundin | Jan 23, 2025 | Leukemia, Sequencing Systems |
OGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read MorePosted by Andy Lundin | Jan 15, 2025 | Hematology & Serology, Molecular Diagnostics |
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
Read MorePosted by Chris Wolski | Dec 20, 2024 | Lung Cancer |
The results of AI-based classifiers for lung cancer using Qlucore Insights were recently presented by researchers.
Read MorePosted by Andy Lundin | Dec 16, 2024 | Leukemia |
Researchers developed a groundbreaking blood test to personalize nanomedicine therapies for leukemia patients, improving treatments.
Read More